Attorneys for 59 women suing Bayer over claims that defective Essure sterilization devices caused perforated uteruses and other medical problems urged a California federal judge at a hearing Thursday to send the case back to state court, arguing the suit brings only state law claims.
The plaintiffs claim Essure — a sterilization product that blocks a woman’s fallopian tubes with a steel coil — can cause perforation of the uterus, device movement or breakage, chronic pain and ectopic pregnancy. These risks didn’t become apparent until after the U.S. Food and Drug Administration approved Essure for sale in the U.S. in 2002, the suit alleges, but Bayer Corp. flouted its duty to give a timely warning to health care providers and the FDA.
Television ads for “low T” have sparked a rise in the use of testosterone gels, patches and injections by older men in recent years, according to a new report. But anyone hoping that a dose of testosterone will provide an easy antidote for sagging muscles, flagging energy and a retiring sex drive may find the results of recent government studies of the sex hormone sobering.
More than 9,000 lawsuits have been filed nationwide against the makers and distributors of the blood thinner Xarelto including more than 7,000 just in Louisiana.
The complaints allege J&J “neglected to inform both patients and doctors of possible severe complications and misrepresented the frequency and severity of risks” from surgical mesh.